Method of modulating a chimeric antigen receptor t cell immune response by administering IL-10
US10195274B2 · kind B2 · utility
3Cited by
56References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 20, 2018 |
| Grant date | Feb 5, 2019 |
| Priority date | — |
| Expiry date | Mar 20, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods of modulating immune responses in subjects having oncology- and immune-related diseases, disorders and conditions by the administration of an IL-10 agent, including pegylated IL-10.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.